FDA Adverse Event Malfunction Summary report: N

2122870-2016-00090

MDR report key: 5448464 · Received February 19, 2016

Report

Report Number
2122870-2016-00090
Event Type
Malfunction
Date Received
February 19, 2016
Date of Event
January 25, 2016
Report Date
January 25, 2016
PMA / PMN Number
K023764
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

PATIENT DEMOGRAPHICS SUCH AS: AGE, DATE OF BIRTH, SEX AND WEIGHT WERE NOT PROVIDED BY THE CUSTOMER. A BECKMAN COULTER FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED TO ASSESS INSTRUMENT PERFORMANCE. WHILE ON SITE THE FSE REPLACED THE SAMPLE PIPETTOR, PERFORMED ALIGNMENTS AND CALIBRATED ALL OF THE PRESSURE SENSORS. AFTER THE REPAIRS WERE COMPLETE, ALL VERIFICATION TESTING PASSED WITHIN PUBLISHED INSTRUMENT AND ASSAY PERFORMANCE SPECIFICATIONS. IN CONCLUSION, THE CAUSE OF THE NON-REPRODUCIBLE ACCESS ACCUTNI+3 RESULTS WAS A HARDWARE MALFUNCTION OF THE SAMPLE PIPETTOR.

Description of Event or Problem · 1

THE CUSTOMER REPORTED OBTAINING NON-REPRODUCIBLE TROPONIN I (ACCESS ACCUTNI+3) RESULTS INVOLVING THE UNICEL DXI 600 ACCESS IMMUNOASSAY SYSTEM SERIAL NUMBER (B)(4) FOR SEVEN (7) PATIENTS. THE ELEVATED ACCESS ACCUTNI+3 SAMPLES FOR PATIENTS ONE (1) THROUGH FOUR (4) WERE REPEATED ON THE SAME UNICEL DXI 600 ACCESS IMMUNOASSAY SYSTEM AND LOWER OR EQUAL RESULTS WERE OBTAINED, BOTH WITHIN AND OUTSIDE OF THE ASSAY'S NORMAL REFERENCE RANGE. THE SAMPLES WERE ALL THEN TESTED ON THE LABORATORY'S ALTERNATE UNICEL DXI 600 ACCESS IMMUNOASSAY SYSTEM SERIAL NUMBER 901077 AND LOWER RESULTS, WITHIN THE ASSAY'S NORMAL REFERENCE RANGE, WERE OBTAINED. THE SAMPLES FOR PATIENTS FIVE (5) THROUGH SEVEN (7) WERE REPEATED ON THE LABORATORY'S ALTERNATE UNICEL DXI 600 ACCESS IMMUNOASSAY SYSTEM SERIAL NUMBER (B)(4) AND LOWER RESULTS, BOTH WITHIN AND OUTSIDE OF THE ASSAY'S NORMAL REFERENCE RANGE, WERE OBTAINED. THE ORIGINAL ELEVATED RESULTS WERE NOT REPORTED OUTSIDE OF THE LABORATORY. THERE WAS NO CHANGE OR IMPACT TO PATIENT CARE OR TREATMENT WHICH OCCURRED IN ASSOCIATION WITH THE NON-REPRODUCIBLE ACCESS ACCUTNI+3 RESULTS. QUALITY CONTROL (QC) RUN AFTER THE GENERATION OF THE NON-REPRODUCIBLE ACCESS ACCUTNI+3 RESULTS DID NOT RECOVER WITHIN CUSTOMER ESTABLISHED RANGES. CALIBRATION WAS PERFORMING WITHIN ASSAY AND INSTRUMENT SPECIFICATIONS AT THE TIME OF THE EVENT. SAMPLE INFORMATION WAS NOT PROVIDED FOR REVIEW. NO ISSUES WITH SAMPLE INTEGRITY WERE NOTED BY THE CUSTOMER. SERVICE WAS REQUESTED AND A BECKMAN COULTER FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED TO ASSESS INSTRUMENT PERFORMANCE.

Patients

Seq Age Sex Outcome Treatment
1